Guiyang Xintian Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QB5
CNY
10.53
-0.11 (-1.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
1,194.72
1,113.33
1,121.93
890.44
828.30
707.44
Shareholder's Funds
1,194.72
1,113.33
1,121.93
890.44
828.30
707.44
Minority Interest
0.00
0.00
0.00
0.00
0.00
1.31
Long-Term Borrowings
553.17
601.87
497.69
450.60
563.88
254.13
Secured Loans
553.17
601.87
497.69
450.60
563.88
254.13
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
12.04
6.40
14.53
-7.89
-6.05
-8.35
Other Long Term Liabilities
29.42
26.67
37.07
13.45
17.72
3.63
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
250.82
222.21
193.75
168.24
177.64
19.80
Current Liabilities
Trade Payables
83.36
105.08
95.67
64.89
44.81
30.77
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
481.38
555.42
501.69
441.23
513.64
332.70
Total Liabilities
1,950.50
1,911.80
1,839.52
1,524.43
1,543.57
1,083.65
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
877.67
858.04
730.12
581.11
489.60
442.09
Less: Accumulated Depreciation
168.84
151.74
136.37
117.17
100.87
85.52
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
708.83
706.30
593.75
463.94
388.73
356.57
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
415.48
386.78
465.17
316.21
187.46
3.93
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
1,333.69
1,275.37
1,228.87
937.60
730.69
493.59
Current Assets Loans & Advances
Current Investments
0.12
0.09
0.11
80.00
118.00
0.00
Inventories
145.48
184.33
183.34
118.77
86.82
94.04
Sundry Debtors
325.67
250.54
261.96
282.72
249.96
263.88
Cash and Bank
118.16
138.24
100.67
72.48
330.09
181.66
Other Current Assets
611.65
621.43
588.80
575.52
803.14
569.57
Short Term Loans and Advances
22.21
48.22
42.72
21.54
18.26
29.99
Total Current Assets
616.81
636.43
610.65
586.83
812.88
590.06
Net Current Assets (Including Current Investments)
135.43
81.00
108.96
145.59
299.24
257.36
Total Current Assets Excluding Current Investments
616.81
636.43
610.65
586.83
812.88
590.06
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,950.50
1,911.80
1,839.52
1,524.43
1,543.57
1,083.65
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
553.17
601.87
497.69
450.60
563.88
254.13
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Guiyang Xintian Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
1,194.72
0
1,194.72
0.00%
Shareholder's Funds
1,194.72
0
1,194.72
0.00%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
553.17
0
553.17
0.00%
Secured Loans
553.17
0
553.17
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
12.04
0
12.04
0.00%
Other Long Term Liabilities
29.42
0
29.42
0.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
250.82
0
250.82
0.00%
Current Liabilities
Trade Payables
83.36
0
83.36
0.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
481.38
0
481.38
0.00%
Total Liabilities
1,950.50
0
1,950.50
0.00%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
877.67
0
877.67
0.00%
Less: Accumulated Depreciation
168.84
0
168.84
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
708.83
0
708.83
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
415.48
0
415.48
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
1,333.69
0
1,333.69
0.00%
Current Assets Loans & Advances
Current Investments
0.12
0
0.12
0.00%
Inventories
145.48
0
145.48
0.00%
Sundry Debtors
325.67
0
325.67
0.00%
Cash and Bank
118.16
0
118.16
0.00%
Other Current Assets
611.65
0
611.65
0.00%
Short Term Loans and Advances
22.21
0
22.21
0.00%
Total Current Assets
616.81
0
616.81
0.00%
Net Current Assets (Including Current Investments)
135.43
0
135.43
0.00%
Total Current Assets Excluding Current Investments
616.81
0
616.81
0.00%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,950.50
0
1,950.50
0.00%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
553.17
0
553.17
0.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period